Results 101 to 110 of about 9,997 (164)

Alpha-Lipoic Acid in Early-Stage Alcohol-Related Brain Damage in Rats: A Comparative Pilot Study. [PDF]

Molecules
Staykov H, Dragomanova S, Hodzhev Y, Grigorova V, Minchev B, Uzunova D, Georgieva A, Sulikovska I, Todorova K, Tsvetanova E, Georgieva A, Stefanova M, Valadbeigi P, Kalfin R, Nikolov R, Tancheva L.   +15 more
europepmc   +1 more source

Pharmacological treatment options for cognitive dysfunction induced by multiple sclerosis: a network meta-analysis. [PDF]

Front Neurol
Fan Z, Liu D, Zhang G, Guo X.
europepmc   +1 more source

Prescribing Cascades: An Umbrella Review and Updated Systematic Review. [PDF]

Drugs Aging
Carollo M, Crisafulli S, Zerio M, Maccarrone F, Paladin A, Selleri M, Forti A, Mattace-Raso FUS, Trifirò G.   +8 more
europepmc   +1 more source

Recent Advances in Nanoparticle-Based Drug Delivery Strategies to Cross the Blood-Brain Barrier in Targeted Treatment of Alzheimer's Disease. [PDF]

Pharmaceutics
Le H, Vu GTT, Abioye A, Adejare A.
europepmc   +1 more source

Comparative efficacy and safety of symptomatic therapy and disease-modifying therapy for Alzheimer's disease: a systematic review and network meta-analysis. [PDF]

Front Neurosci
Liu S, Zhao M, Liu Y, Yang X, Yan H, Xu H, Wu Y, Xu Y.   +7 more
europepmc   +1 more source

Recurrent Cholinergic Crisis Caused by Therapeutic-Dose Rivastigmine Patch in an Elderly Patient With Alzheimer's Disease: A Case Report. [PDF]

Cureus
Matsuura K, Mayahara T, Katayama T, Arai H.   +3 more
europepmc   +1 more source

Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson's disease without dementia: a systematic review. [PDF]

BMJ Neurol Open
Cani I, Grotteschi N, Calandra-Buonaura G, Guarino M, Guaraldi P, Giannini G, Baldelli L, Donati M, Cortelli P, Camerlingo MD, Nonino F, Sambati L.   +11 more
europepmc   +1 more source